Estrogen-related receptors (ERRs) are a group of nuclear receptors that share sequence homology with ER whereas do not bind to Estrogen. In this article, studies were conducted with ERRβ, which is considered to have antiproliferative capabilities, to summarize its effects upon overexpression and knockdown. Clonogenic assay, and vivo zebra fish model tumour xenograft assay was used to detect the tumour growth and suppression. Wound healing and trans well migration as well as invasion assays were used to detect the metastasis in breast cancer. In this study, we established ERRβ as a possible tumour suppressor. Furthermore, epithelial-mesenchymal transition (EMT) pathway was checked with respective markers and it was observed that ERRβ overexpression in MCF7 and MDAMB -231 cells reduced the expression of mesenchymal markers where in promoting an upregulation of epithelial markers. Using triple negative MDAMB 231 cell lines, the zebra fish model was also utilized to check for tumor growth and migration. It was discovered that overexpression of the ERRβ resulted in a considerable reduction in the size of the tumor and its metastasis. Overall, our research showed that ERRβ interferes with breast cancer cell ability to proliferate and metastasize. Therefore, emphasizing on the function of ERRβ and, in turn, the process of EMT, may prevent the oncogenesis and metastasis in breast cancer cells.

Keywords: Breast Cancer; Estrogen Related Receptor Beta (ERRβ); Estrogen Receptor; Estrogen Related Receptor

References

1. Ariazi Eric A., et al. “Estrogen-related receptor alpha and Estrogen-related receptor gamma associate with unfavourable and favourable biomarkers, respectively, in human breast cancer”. Cancer Research22 (2002): 6510.
2. Cooper J A., et al. “Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study”. British Journal of Cancer1 (1989): 119-125.
3. Cowley S M., et al. “Estrogen receptors alpha and beta form heterodimers on DNA”. The Journal of Biological Chemistry32 (1997): 19858-19862.
4. Divekar Shailaja D., et al. “Estrogen-related receptor β (ERRβ) - renaissance receptor or receptor renaissance?”. Nuclear Receptor Signaling 14 (2016): e002.
5. Giguère V. “Orphan nuclear receptors: from gene to function”. Endocrine Reviews5 (1999): 689-725.
6. Gronemeyer H. “Transcription activation by estrogen and progesterone receptors”. Annual Review of Genetics 25 (1991): 89-123.
7. Hawkins M B., et al. “Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts”. Proceedings of the National Academy of Sciences of the United States of America20 (2000): 10751-10756.
8. Horard B and J-M Vanacker. “Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand”. Journal of Molecular Endocrinology3 (2003): 349-357.
9. Huss Janice M., et al. “Constitutive activities of estrogen-related receptors: Transcriptional regulation of metabolism by the ERR pathways in health and disease”. Biochimica et Biophysica Acta9 (2015): 1912-1927.
10. Klinge C M. “Estrogen receptor interaction with estrogen response elements”. Nucleic Acids Research14 (2001): 2905-2919.
11. Kumari Kanchan., et al. “Estrogen-related receptors alpha, beta and gamma expression and function is associated with transcriptional repressor EZH2 in breast carcinoma”. BMC cancer1 (2018): 690.
12. Lazennec G., et al. “ER beta inhibits proliferation and invasion of breast cancer cells”. Endocrinology 142.9 (2001): 4120-4130.
13. Lewis-Wambi Joan S and V Craig Jordan. “Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs)”. Breast disease 24 (2005): 93-105.
14. Lu D., et al. “Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors”. Cancer Research18 (2001): 6755-6761.
15. Madhu Krishna B., et al. “Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer”. BMC cancer1 (2018): 607.
16. Mukherjee Shibani and Susan E Conrad. “c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells”. The Journal of Biological Chemistry18 (2005): 17617-17625.
17. Paruthiyil Sreenivasan., et al. “Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest”. Cancer Research 1 (2004): 423-428.
18. Perou C M., et al. “Molecular portraits of human breast tumours”. Nature6797 (2000): 747-752.
19. Pettersson K., et al. “Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha”. Molecular Endocrinology (Baltimore, Md.)10 (1997): 1486-1496.
20. Sengupta D., et al. “ERRβ signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells”. British Journal of Cancer8 (2014): 2144-2158.
21. Ström Anders., et al. “Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D”. Proceedings of the National Academy of Sciences of the United States of America 6 (2004): 1566-1571.
22. Sung Hyuna., et al. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”. CA: A Cancer Journal for Clinicians3 (2021): 209-249.
23. Tremblay G B., et al. “Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex”. Molecular and Cellular Biology 3 (1999): 1919-1927.
24. Wang Xia and Yong Lin. “Tumor necrosis factor and cancer, buddies or foes?”. Acta pharmacologica Sinica11 (2008): 1275-1288.
25. Wu Wan-fu., et al. “Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis”. Proceedings of the National Academy of Sciences of the United States of America9 (2013): 3543-3548.
26. Yu S., et al. “Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21 (WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer”. Oncogene23 (2008): 3313-3328.

Citation

Citation: Sandip K Mishra.,et al. “More Evidences for the Possible Role of Err Beta (ERRβ) as a Tumor Suppressor in Estrogen Receptor Positive and Negative Breast Cancer”.Acta Scientific Cancer Biology 8.3 (2024): 03-08.

Copyright

Copyright: © 2024 Sandip K Mishra.,et al. “Study of p16INK4a Immunostaining as Specific Biomarker in the diagnosis of Cervical Intraepithelial Neoplasia and This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.